SGHT - Sight Sciences, Inc.
IEX Last Trade
3.56
0.040 1.124%
Share volume: 1,778
Last Updated: Fri 27 Dec 2024 08:29:12 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$3.52
0.04
1.14%
Fundamental analysis
42%
Profitability
60%
Dept financing
13%
Liquidity
75%
Performance
22%
Performance
5 Days
2.85%
1 Month
-7.67%
3 Months
-44.55%
6 Months
-44.80%
1 Year
-38.40%
2 Year
-69.07%
Key data
Stock price
$3.56
DAY RANGE
$3.48 - $3.68
52 WEEK RANGE
$3.56 - $8.45
52 WEEK CHANGE
-$30.04
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Paul Badawi
Region: US
Website: sightsciences.com
Employees: 210
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: sightsciences.com
Employees: 210
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Sight Sciences, Inc. engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. Its products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Recent news